SPY765.29−0.04%QQQ736.21−0.04%BTC/USD83,171.70−1.51%DIA513.91−0.02%GLD377.25−0.17%TLT78.68+0.08%
Benzinga

Stock Trading Ideas

Trading Ideas Recent News

Stock of the Day: Is This the Bottom for Gen Digital?
Stock of the Day: Is This the Bottom for Gen Digital?
Gen Digital nears $20.50, a former resistance that could become support, potentially sparking a rebound after its post-GoDaddy bid selloff.
Crypto Stock Short Squeeze? Investors Are Shorting These 3 Stocks to Hedge Bitcoin’s Rise
Crypto Stock Short Squeeze? Investors Are Shorting These 3 Stocks to Hedge Bitcoin’s Rise
S3 Partners names three crypto related stocks seeing high short interest that could be short squeeze candidates if Bitcoin keeps going up in price.
General Motors Stock Falls Monday: What's Going On?
General Motors Stock Falls Monday: What's Going On?
General Motors shares are trading lower Monday in line with broader auto sector weakness amid rising Treasury yields and oil prices.
American Airlines Stock's New Floor Holds, But Resistance Remains
American Airlines Stock's New Floor Holds, But Resistance Remains
American Airlines Group shares are trading lower Monday. Two analysts cut their price targets on the stock. Here's what you need to know.
Seagate Shares Rise Over 6% After Key Trading Signal
Seagate Shares Rise Over 6% After Key Trading Signal
A key trading signal flashed for Seagate shares at a price of $872.35, after which STX rose over 6% to an intraday high.
DraftKings Stock Dips Due to Flutter's Weakness
DraftKings Stock Dips Due to Flutter's Weakness
DraftKings is falling Monday, likely in sympathy with peer Flutter Entertainment after Brazil moved to ban online sports betting and iGaming.
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Analysts downgraded PepsiCo, RLJ Lodging Trust, Braskem.
AbbVie’s New Parkinson’s Pill Could Become a Billion-Dollar Drug, Analyst Says
AbbVie’s New Parkinson’s Pill Could Become a Billion-Dollar Drug, Analyst Says
FDA approves AbbVie's Juvmo for Parkinson's disease, the first D1/D5 agonist. U.S. launch set for Oct 2026. Get pricing and sales data.
IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch
IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch
Bank of America rates IonQ a Buy with a $60 price target, citing its chip-based quantum roadmap and SkyWater deal.
GE Aerospace Secures Polish Defense Deal, But Broad Industrial Pullback Weighs on Shares
GE Aerospace Secures Polish Defense Deal, But Broad Industrial Pullback Weighs on Shares
GE Aerospace Poland expansion adds local military engine support as industrial weakness and valuation pressure shares.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved